Health R&D saves lives, spurs innovation, and solidifies success
USAID’s latest report to Congress demonstrates how strategic R&D investments are driving positive global health outcomes and saving American taxpayers money
Sign up to receive news and updates from GHTC.
USAID’s latest report to Congress demonstrates how strategic R&D investments are driving positive global health outcomes and saving American taxpayers money
2018 is shaping up to be another important year for US policy related to global health and medical research. As Congress returns for a busy work session and the White House continues to roll out policy reforms, here are the top five issues GHTC will be following in 2018.
As we close out our 10th anniversary year, we wanted to take a moment to reflect on our shared progress and celebrate the headlines and moments that shaped global health R&D over the past decade. Check out some of the highlights...
On Tuesday, the Trump Administration released its full fiscal year 2018 budget proposal. This budget proposes significant cuts to programs that support global health and medical research at the National Institutes of Health, Centers for Disease Control and Prevention, and the US Agency for International Development.